top of page
Search

DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities

Updated: Mar 14, 2023


FOR IMMEDIATE RELEASE Contact: DEA Public Affairs (571) 776-2508


Press Release

DEA extends many telemedicine flexibilities adopted during the COVID-19 PHE with appropriate safeguards


WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules.


Comentarios


bottom of page